Hugh M Cole's Net Worth
$419 Thousand
Who is Hugh M Cole?
Hugh M Cole does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Jounce Therapeutics, Inc., Astria Therapeutics, Inc., and ARIAD PHARMACEUTICALS INC.
SEC CIK
Hugh M Cole's CIK is 0001604646
Past Insider Trading and Trends
2016 was Hugh M Cole's most active year for acquiring shares with 7 total transactions. Hugh M Cole's most active month to acquire stocks was the month of May. 2016 was Hugh M Cole's most active year for disposing of shares, totalling 7 transactions. Hugh M Cole's most active month to dispose stocks was the month of December. 2021 saw Hugh M Cole paying a total of $689,676.00 for 190,100 shares, this is the most they've acquired in one year. In 2021 Hugh M Cole cashed out on 34,219 shares for a total of $257,942.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jounce Therapeutics, Inc. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.13% | -16.63K |
$1.11 | -$18,481.04 | 110.08K |
Jan 9 - Jan 10
| |||
Form 4
| +18.74% | 20K |
—
|
—
| 126.72K |
Aug 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +66.18% | 42.5K |
—
|
—
| 106.72K |
Feb 1
| |||
Form 4
| -13.09% | -9.67K |
$6.88 | -$66,579.65 | 64.22K |
Jan 7 - Jan 10
| |||
Form 4
| +56.58% | 26.7K |
—
|
—
| 73.89K |
Feb 1
| |||
Form 4
| -14.50% | -8.00K |
$8.72 | -$160,350.00 | 47.19K |
Scheduled
|
Jan 22
| ||
Form 4
| -10.13% | -6.22K |
$6.89 | -$42,842.04 | 55.19K |
Jan 7 - Jan 8
| |||
Form 4
| -3.43% | -2.18K |
$4.71 | -$10,276.44 | 61.41K |
Aug 14 - Aug 18
| |||
Form 4
| +89.31% | 30K |
—
|
—
| 63.59K |
Feb 3
| |||
Form 4
| -7.25% | -2.62K |
$7.78 | -$20,414.72 | 33.59K |
Jan 7
| |||
Form 4
| -6.06% | -2.34K |
$3.99 | -$9,329.56 | 36.21K |
Aug 14 - Aug 16
| |||
Form 4
| +136.50% | 22.25K |
—
|
—
| 38.55K |
Feb 1
| |||
Form 4
| +757.89% | 14.4K |
—
|
—
| 16.3K |
Aug 13
| |||
Form 4
|
∞
| 1.9K |
$7.84 | $14,896.00 | 1.9K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astria Therapeutics, Inc. (ATXS) Snapshot price: $14.795
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARIAD PHARMACEUTICALS INC No price found
SVP, Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -42.83K |
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +43.18% | 12.92K |
$8.69 | -$54,303.81 | 42.83K |
Jun 25 - Feb 6
| |||
Form 4
| +78.48% | 13.15K |
$7.05 | -$42,384.60 | 29.92K |
Jun 27 - Jun 28
| |||
Form 4
| +231.13% | 11.7K |
$7.18 | -$40,452.12 | 16.76K |
Apr 29
| |||
Form 4
|
∞
| 5.06K |
$6.21 | $31,435.02 | 5.06K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||